Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

Changes in the HR gene have influenced hair growth and may lead to hair loss conditions in humans.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Activin A and follistatin control when hair cells develop in mouse ears.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Giving a special protein to dogs with a certain genetic disease improved their symptoms but didn't help with hair growth.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

A new keratin, hK6irs1, is found in all layers of the hair follicle's inner root sheath.

A specific gene mutation causes congenital hair loss.

Researchers made stem cells from human hair follicle cells with better efficiency than from skin cells.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Canine hair follicles have stem cells similar to human hair follicles, useful for studying hair disorders.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Keratin genes change gradually during skin cell development and should be used carefully as biomarkers.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

The gene KAP22-1 affects wool yield and fiber shape in sheep.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Certain gene variations might be linked to severe acne in women but not in men.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

FLCN helps control iron levels in cells.